This call presents a unique opportunity to advance innovative approaches in drug discovery and translational research for rare diseases. At EU-OPENSCREEN, we want to make a meaningful contribution to accelerate the development of new therapies of highly needed therapies in the area.
We invite researchers to partner with us as we work together to

• Build strong, multidisciplinary consortia: We can join your team as a partner and connect you with our partner sites and other experts from our network dedicated to tackling rare diseases.
• Create impactful proposals: Together, we can design an impactful project aligned with the call’s focus.
• Leverage cutting-edge RI resources and services: As partner, we can provide you with access to our drug discovery and chemical biology platforms to strengthen your proposal.

Call preliminary announcement: https://erdera.org/wp-content/uploads/2024/10/Pre-announcement-JTC-2025_final-1.pdf

Let’s connect and reach out early to explore pathways of collaboration with us and get started by contacting us via: scientific-services@eu-openscreen.eu. (Pre-proposal submission deadline: February 13, 2025)

We look forward to making a meaningful impact together with you!